Login / Signup

Biosense Webster's QDOT Micro™ radiofrequency ablation catheter.

Jean-Yves WielandtsAlexandre AlmoradGabriela HilfikerKris GillisMilad El HaddadJohan VijgenBenjamin BerteJean-Benoît Le Polain de WarouxRené TavernierMattias DuytschaeverSebastian Knecht
Published in: Future cardiology (2021)
The QDOT Micro™ catheter (Biosense Webster, Inc., CA, USA) is a new radiofrequency ablation catheter based on the SmartTouch SF™ (Biosense Webster, Inc.). It combines diffuse external irrigation with six thermocouples located within the outer metal shell and three additional microelectrodes in a 3.5 mm-tip contact force radiofrequency catheter. This article focuses on the different characteristics of the catheter, which incorporates the ability of high power delivery, irrigation flow control based on temperature sensing through the six thermocouples and the generation of microelectrograms. An outline of its performance in preclinical and clinical setting is presented, showing promising results, especially concerning procedural efficiency and short-term safety. Additional studies need to confirm long-term effectiveness, and durability studies should evaluate whether superiority on a lesion quality level can be achieved.
Keyphrases
  • radiofrequency ablation
  • ultrasound guided
  • randomized controlled trial
  • systematic review
  • single molecule
  • low grade
  • mesenchymal stem cells
  • quality improvement